Calibrate

📍 New York, United States🗓 Founded 2020👥 362 employees💰 Last funded Jan 2024
Calibrate is on a mission to change the way the world treats weight. As the leading clinician-guided and value-based outcomes model in obesity treatment, Calibrate combines medication with transformative behavior change to improve overall metabolic health, driving cost-effective, long-term weight loss results while reducing the total cost of care for employers and payers. Recognized by esteemed organizations, including the World Economic Forum’s Technology Pioneers, Fast Company’s World Changing Ideas, TIME’s Best Inventions, and the Employer Health Innovation Roundtable Traction Awards. Calibrate is backed by leading healthcare investors, including Madryn Asset Management, and Redesign Health.
4
Total investors
3
Early stage
1
Mid stage
0
Late stage
2020
Founded
Investor geography2 countries
United States
3
Israel
1
Investor activity2021–2024 · investors recorded per year
202112022220241
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Calibrate?
Calibrate has 4 investors on record on gritt.io, including 3 early-stage backers, 1 mid-stage.
When did Calibrate last raise funding?
The most recent investment in Calibrate recorded on gritt.io was in January 2024.
When was Calibrate founded?
Calibrate was founded in 2020.
What industry is Calibrate in?
Calibrate operates in Health, Wellness & Fitness. Find similar Health, Wellness & Fitness investors on gritt.io.
Where is Calibrate based?
Calibrate is headquartered in New York, United States.